Ibrahim, A. S., Spellberg, B. J., Avanesian, V., Fu, Y., & Edwards, J. E. (2006). The Anti-Candida Vaccine Based on the Recombinant N-Terminal Domain of Als1p Is Broadly Active against Disseminated Candidiasis. American Society for Microbiology.
Citação norma ChicagoIbrahim, Ashraf S., Brad J. Spellberg, Valentina Avanesian, Yue Fu, and John E. Edwards. The Anti-Candida Vaccine Based On the Recombinant N-Terminal Domain of Als1p Is Broadly Active against Disseminated Candidiasis. American Society for Microbiology, 2006.
MLA引文Ibrahim, Ashraf S., et al. The Anti-Candida Vaccine Based On the Recombinant N-Terminal Domain of Als1p Is Broadly Active against Disseminated Candidiasis. American Society for Microbiology, 2006.
警告:這些引文格式不一定是100%准確.